Lalitha K Shankar

Lalitha K Shankar

UNVERIFIED PROFILE

Are you Lalitha K Shankar?   Register this Author

Register author
Lalitha K Shankar

Lalitha K Shankar

Publications by authors named "Lalitha K Shankar"

Are you Lalitha K Shankar?   Register this Author

26Publications

705Reads

9Profile Views

Guidelines for quality control of PET/CT scans in a multicenter clinical study.

EJNMMI Phys 2017 Sep 18;4(1):23. Epub 2017 Sep 18.

Department of Nuclear Medicine, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40658-017-0190-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603471PMC
September 2017

Beyond Correlations, Sensitivities, and Specificities: Case Examples of the Evaluation of Advanced Imaging in Oncology Clinical Trials and Cancer Treatment.

Acad Radiol 2017 08 11;24(8):1027-1035. Epub 2017 Apr 11.

Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2016.11.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511062PMC
August 2017

Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design.

Acad Radiol 2017 08 26;24(8):1036-1049. Epub 2017 Apr 26.

Cancer Imaging Program, Division of Cancer Treatment, Diagnosis National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2017.03.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547568PMC
August 2017

Imaging biomarker roadmap for cancer studies.

Nat Rev Clin Oncol 2017 03 11;14(3):169-186. Epub 2016 Oct 11.

CRUK and EPSRC Cancer Imaging Centre in Cambridge and Manchester, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378302PMC
March 2017

Clinical Translation of the National Institutes of Health's Investments in Nanodrug Products and Devices.

AAPS J 2017 03 19;19(2):343-359. Epub 2016 Dec 19.

Diagnostic Imaging Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Rockville, Maryland, 20850, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12248-016-9995-xDOI Listing
March 2017

A risk management approach for imaging biomarker-driven clinical trials in oncology.

Lancet Oncol 2015 Dec;16(16):e622-8

Humanitas University and Nuclear Medicine Department, Humanitas Research Hospital, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00164-3DOI Listing
December 2015

Are we ready for the 10% solution?

Oncologist 2014 May 22;19(5):439-40. Epub 2014 Apr 22.

Cancer Therapy Evaluation Program, Biometric Research Branch, and Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/content/19/5/439.full
Web Search
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2014-0126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012974PMC
May 2014

The clinical evaluation of novel imaging methods for cancer management.

Nat Rev Clin Oncol 2012 12 13;9(12):738-44. Epub 2012 Nov 13.

National Cancer Institute, Cancer Imaging Program, Chief Diagnostic Imaging Branch, 6130 Executive Boulevard, Bethesda, MD 20892 7412, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2012.186DOI Listing
December 2012

Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis.

J Nucl Med 2012 May 10;53(5):701-8. Epub 2012 Apr 10.

Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.111.095299DOI Listing
May 2012

Considerations for the use of imaging tools for phase II treatment trials in oncology.

Clin Cancer Res 2009 Mar 10;15(6):1891-7. Epub 2009 Mar 10.

Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2030DOI Listing
March 2009

Standardization of PET Imaging in Clinical Trials.

PET Clin 2008 Jan 27;3(1):1-4. Epub 2008 Nov 27.

Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd., Room 6056, Bethesda, MD 20892-7412, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2008.10.006DOI Listing
January 2008

PET/CT in cancer patient management. Commentary.

J Nucl Med 2007 Jan;48 Suppl 1:1S

Cancer Imaging Program, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
January 2007

Functional imaging in lung cancer.

J Clin Oncol 2005 May;23(14):3203-11

Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.08.854DOI Listing
May 2005

Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.

J Nucl Med 2002 Jan;43(1):72-6

Division of Nuclear Medicine, Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
January 2002